Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anika Therapeutics, Inc.ANIK · Entity 6005 | Director | June 18, 2026 | June 23, 2026 |
| Neuronetics, Inc.STIM · Entity 6248 | Director | May 28, 2026 | May 29, 2026 |
| SURGALIGN HOLDINGS, INC.SRGA · Entity 109633 | Director | August 15, 2022 | August 17, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anika Therapeutics, Inc.
Report date June 18, 2026 · Filed June 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,970 |
Reported balance
After 2026-06-18 transaction · row 1
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 10,402 · Balance 52,970 F1: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027.
Neuronetics, Inc.
Report date May 28, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 251,716 |
Reported balance
After 2026-05-28 transaction · row 1
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 30,000 · Balance 251,716 F1: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date.
F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
SURGALIGN HOLDINGS, INC.
Report date August 15, 2022 · Filed August 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,783 |
Reported balance
After 2022-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-08-15 · Grant · Acquired 22,857 · Balance 24,783 F1: Represents restricted stock units of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant. F2: The total shares reported reflect 1:30 reverse stock split on May 17, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant.
F2: The total shares reported reflect 1:30 reverse stock split on May 17, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2026 Filed Jun 23, 2026 20:30 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 10,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-279535 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,970 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:02 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001238659-26-000002 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,716 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 20, 2025 Filed Oct 22, 2025 20:45 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 7,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-246922 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,716 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2 · shares: Represents a restricted stock unit ("RSU") award that vested immediately upon the grant. F3 · price: Each RSU represents a right to receive one share of the Issuer's common stock. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 21:05 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 14,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-25-004064 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,568 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026. Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:00 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077827 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,390 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 22, 2026 or (b) the Reporting Person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 22:20 UTC | Neuronetics, Inc. STIM · Entity 6248 | OtherCommon Stock | 44,444 | $2.25 | $99,999.00 |
DisclosureSEC source: 0000950170-25-017198 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,390 F1 · kind: On February 7, 2025, the Reporting Person purchased 44,444 shares of the Issuer's Common Stock in connection with a firm commitment underwritten offering. Read SEC document |
| July 09, 2024 Filed Jul 11, 2024 20:32 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 5,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-24-003904 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,404 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2025 annual meeting of the Company's stockholders or July 9, 2025. Read SEC document |
| May 30, 2024 Filed Jun 6, 2024 00:19 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-069573 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,946 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 30, 2025, or (b) the reporting person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the reporting person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:15 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-23-003957 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,633 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2024 annual meeting of the Company's stockholders or June 14, 2024. Read SEC document |
| May 25, 2023 Filed May 30, 2023 21:59 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 36,364 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-23-012472 · form4.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,946 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 23, 2024, or (b) the reporting person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the reporting person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 16:36 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | GrantCommon Stock | 22,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-046161 · doc4.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,783 F1 · shares: Represents restricted stock units of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant. F2 · balance_after: The total shares reported reflect 1:30 reverse stock split on May 17, 2022. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:16 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 7,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-22-004298 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,133 F1 · shares: These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on the earlier of the 2023 annual meeting of the Company's stockholders or June 8, 2023. Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:29 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 38,910 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-013870 · form4.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,582 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 26, 2023, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 28, 2021 Filed Nov 1, 2021 21:43 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 8,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-21-007368 · ownership.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,179 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning on October 28, 2022. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 23:15 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 6,200 | $14.03 | $87,004.60 |
DisclosureSEC source: 0001062993-21-005379 · form4.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,672 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $13.75 to $14.30. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 22:28 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 6,800 | $13.78 | $93,683.60 |
DisclosureSEC source: 0001062993-21-005246 · form4.xml · nonDerivative · entry 2 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,872 F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $13.75 to $13.92. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 22:28 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 7,137 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-21-005246 · form4.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,672 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 27, 2022, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:40 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | GrantOption to purchase common stock $.001 par value · Derivative | 108,978 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001209191-21-031353 · doc4.xml · derivative · entry 2 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,978 Underlying: Common Stock · 108,978 shares Expires 2031-05-07 F2 · derivative.exercise_date: The option becomes exercisable on the first anniversary of the date of grant. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:40 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | GrantCommon Stock | 57,803 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031353 · doc4.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,803 F1 · shares: Represents restricted stock units of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant. Read SEC document |
| May 07, 2021 Filed Jul 2, 2021 20:05 UTC Amendment | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | GrantOption to purchase common stock $.001 par value · Derivative | 114,091 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001209191-21-044886 · doc4a.xml · derivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,091 Underlying: Common Stock · 114,091 shares Expires 2031-05-07 F1 · shares: The Form 4 filed on 5/7/2021 for an option which becomes exercisable on the first anniversary of the date of grant erroneously reported 108,987 shares in column five. The purpose of this amendment is to correct the total underlying shares in columns five, seven and nine. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 20:45 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 12,291 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-20-000645 · edgar.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,535 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) August 5, 2021, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:41 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-20-000410 · edgar.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,244 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 26, 2021, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 20:10 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantStock Option (right to buy) · Derivative | 6,630 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001192482-19-000377 · edgar.xml · derivative · entry 2 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,630 Underlying: Common Stock · 6,630 shares Expires 2029-10-30 F3 · derivative.exercise_date: The option shall vest on the earlier of (a) October 30, 2020, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 20:10 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 3,244 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-19-000377 · edgar.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,244 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) October 30, 2020, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.